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MULTIPLE PLEXIFORM SCHWANNOMAS IN A PATIENT WITH NEUROFIBROMATOSIS
Salwa Sheikh, MD,a Mario Gomes, MD,b and Elizabeth Montgomery, MD,a Washington, D.C.
Plexiform schwannomas are unusual benign peripheral
nerve sheath tumors, and rare cases have been reported in
the setting of “schwannomatosis.” We are aware of only a
single case having been reported in a patient with neuro-
fibromatosis type 2 (NF-2). We present a case of multiple
spinal, chest wall, esophageal, and paraesophageal plexi-
form schwannomas in a patient with NF-2. Emphasis is
placed on correct identification of plexiform schwannoma
and its distinction from plexiform neurofibroma and other
tumors having a plexiform growth pattern.
A 37-year-old man with NF-2 was referred for treat-
ment of hoarseness and left vocal cord paralysis. Com-
puted tomographic scan and magnetic resonance imaging
revealed a mediastinal mass. The patient’s history was
significant for bilateral acoustic schwannomas, a left pari-
etal meningioma, multiple neurofibromas, and multiple
intradural and extradural schwannomas. He underwent a
right thoracotomy with resection of paraesophageal, ret-
ropharyngeal, and chest wall masses. The postoperative
course was uneventful. All three specimens consisted of
irregular multinodular masses.
On histologic examination, the specimen consisted of
multiple nodules of tumor, each separated by strands of
nonneoplastic connective tissue (Fig. 1). Some nodules
were highly cellular and composed of spindle cells. Char-
acteristic cellular Antoni A areas with nuclear palisading
(Fig. 2), Verocay bodies, and short parallel fascicles of
Schwann cells juxtaposed with hypocellular myxoid An-
toni B regions were uniformly present. Neither necrosis
nor hemorrhage was seen.
Schwannomas are usually solitary neoplasms. Although
their most common location is the acoustic nerve, they
may arise anywhere along the course of cranial or periph-
eral nerves. Multiple schwannomas may be noted as an
isolated finding but are observed more commonly in
patients with NF. Plexiform schwannomas are also benign
peripheral nerve sheath tumors. In 1984 Shishiba and
associates1 introduced the term “schwannomatosis” for a
syndrome characterized by multiple cutaneous schwanno-
mas, central nervous system tumors, and various neuro-
logic deficits without stigmata of NF.1 In 1995 Val-Bernal,
Figols, and Vasquez-Barquero2 summarized 78 cases of
plexiform schwannomas already reported in the literature;
eight were associated with clinical schwannomatosis, six
with multiple cutaneous schwannoma syndrome, and only
three with NF-1. They also reported, for the first time in
the literature, a single case of plexiform schwannoma in a
patient with NF-2. Rare cases have been reported in
association with NF-1 schwannomatosis. In 1996, Reith
and Goldblum3 reported a case of multiple cutaneous
plexiform schwannomas associated with bilateral acoustic
neuromas, as well as other intracranial and intraspinal
neoplasms,3 which may represent another example of
plexiform schwannoma in NF-2.
Essentially, multifocal Schwann cell proliferation may
be separated into three groups2: (1) multifocal micro-
scopic schwannomatosis, (2) clinical schwannomatosis,
and (3) multiple cutaneous schwannomas. Patients with
multiple cutaneous schwannomas have hyperacousis asso-
ciated with various intracranial tumors. Clinical schwan-
nomatosis is distinguished from NF-1 by its lack of skin
pigmentation, neurofibromas, and autosomal dominant
transmission. Multiple cutaneous schwannomas are unas-
sociated with intracranial tumors. Some of these tumors
may develop along the course of a large nerve segment.
Like those with NF-2, patients with cutaneous schwanno-
mas have loss of heterozygosity of chromosome 22. Be-
cause the cutaneous schwannoma locus is present in the
NF-2 region, this may well represent a subtype of NF-2.
Plexiform schwannoma consists of multiple intradermal
or subcutaneous nodules composed primarily of cellular
Antoni A regions with nuclear palisading and Verocay
bodies. These tumors, like their more typical counter-
parts, are composed almost exclusively of Schwann cells
without evidence of axons. No malignant transformation
has been reported, although local recurrence has been
associated with incomplete resection. Plexiform schwan-
noma must be differentiated from several other entities,
including plexiform neurofibroma, plexiform fibrohistio-
cytic tumor, plexiform malignant peripheral nerve sheath
tumor of infancy and childhood, plexiform granular cell
tumor, and traumatic neuroma. Plexiform neurofibroma is
a plexiform tumor composed of Schwann cells, perineural
cells, fibroblasts, and axons admixed with collagen in a
loose matrix. The term plexiform refers to the serpentine
distortion it imparts to the affected nerve segment, which
has been likened to a “bag of worms.” It is critical to
distinguish plexiform schwannoma from plexiform neuro-
fibroma, because the latter is pathognomonic for NF-1
and carries a risk of malignant transformation, in contrast
to the former. Plexiform fibrohistiocytic tumor is rare and
was first described by Enzinger and Zhang5 in 1988. It
usually arises in children or young adults, being more
common in girls and young women. It is characterized by
fibroblasts variably admixed with osteoclast-like giant
cells. Although regional lymph node metastases have been
reported, neither visceral metastases nor tumor-related
deaths have been documented. The so-called plexiform
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malignant peripheral nerve sheath tumor of infancy and
childhood was described in 1994 by Meis-Kindblom and
Enzinger,6 who related the findings in nine cases of a
plexiform neoplasm in which there were morphologic
features similar to plexiform schwannomas but which
differed by having mitoses and lacking Antoni B zones.
Although no lesion metastasized, the authors assumed the
view that these were malignant neoplasms. Other authors,
however, believe that the lesions described by Meis-
Kindblom and Enzinger6 are instead examples of plexi-
form variants of cellular schwannomas,7 benign tumors
that are known to be cellular, mitotically active, able to
erode bone, and frequently congeners of sarcomas.
In summary, we present a case of plexiform schwan-
noma in a patient with NF-2. In such a setting it is critical
to distinguish the plexiform schwannoma from plexiform
Fig. 1. Scanning power view of plexiform schwannoma. Note the multiplicity of lobules of varying sizes
with unremarkable connective tissue in between, an appearance imparted by distortion of an affected nerve
segment represented in two dimensions.
Fig. 2. Palisaded nuclei are illustrated to their advantage in this field.
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neurofibroma, because the clinical and prognostic impli-
cations differ substantially for the two.
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AXILLARY ARTERY–CORONARY ARTERY BYPASS GRAFTING
Eduardo A. Tovar, MD, Nathan Blau, MD, and Alan Borsari, MD, Fullerton and Orange, Calif.
Recently, an operation first described in 1952 by
Demikhov1 and further developed by Kolesov and Pot-
ashov2 has reemerged as a minimally invasive procedure
in which the left internal thoracic artery (LITA) is anas-
tomosed to the left anterior descending coronary artery
(LAD) in a beating heart. An anterior mediastinotomy is
used to gain access to both arteries. We, like others,3 have
used the descending thoracic aorta and the left subclavian
artery as inflow conduits to perform coronary bypass
procedures without extracorporeal circulation. Recently,
however, we encountered a case in which these sources of
inflow could not be used. We had to resort to the axillary
artery to perform the proximal anastomosis. To tunnel the
graft into the chest cavity, we resected the anterior portion
of the first rib and performed the rest of the operation
through an anterior mediastinotomy.
A 63-year-old man was admitted with congestive heart
failure, severe pulmonary edema, and liver and renal
dysfunction. The patient had undergone three previous
coronary bypass operations. The most recent one, in 1995,
was performed on an urgent basis after failure of a stent to
reopen the anastomotic site between the LITA and the
LAD. According to the surgeon’s operative note at the
specialized stent center, the patient had a complicated
operation that required delayed sternal closure and a
prolonged hospital stay. Sixteen months later, the patient
began to have recurrent anginal symptoms and frequent
episodes of congestive heart failure, which culminated
with this admission. A coronary angiogram showed a
completely absent native circulation, two patent grafts to
the right coronary system, a patent graft to an obtuse
marginal branch, and the LITA, implanted in 1976, which
precariously supplied the LAD system. The ejection frac-
tion, as in the patient’s previous operation, was calculated
at 20%. The patient underwent an axillary artery–LAD
bypass with a reversed lesser saphenous vein graft. No
inotropic medications were needed, and the patient did
not require any blood or blood components. The patient
was kept in the intensive care unit overnight and was
transferred to the regular department on the first postop-
erative day. Two days after the operation the patient was
discharged from the hospital, receiving only nonprescrip-
tion medication for pain. Two weeks after the operation,
before the patient started a cardiac rehabilitation pro-
gram, a Doppler study showed excellent function of the
graft.
Operative technique. The left arm is abducted no more
than 90 degrees. A 5 cm transverse incision is performed
2 cm below and parallel to the clavicle just lateral to the
sternochondral junction. The pectoralis major muscle is
split in an avascular plane between its clavicular and
sternal heads. The first rib is identified and the intercostal
muscles inserted in its inferior aspect are divided. A
periosteal elevator is used to free the underside of the rib
from the pleura. The subclavius, anterior scalene, and
middle scalene muscles are carefully divided on top of the
rib, gently retracting the axillary vessels. The rib is divided
with a rongeur at the costochondral junction and then
transected posteriorly with a rib shears. The axillary artery
is circumferentially mobilized. A second 8 cm transverse
incision is performed over the fourth costal cartilage. The
cartilage is excised and the pericardium overlying the
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